The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Seelos Therapeutics, Inc(NASDAQ:SEEL) 
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel technologies and therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic...
Website: http://www.seelostx.com
Founded: 2016
Full Time Employees: 8
Sector: Healthcare
Industry: Biotechnology
Seelos Therapeutics Days Payable Outstanding ttm (DPO)
Seelos Therapeutics Days Receivable Outstanding ttm (DSO)
Seelos Therapeutics Days Inventory Outstanding ttm (DIO)
Seelos Therapeutics Op Cashflow Per Share ttm
Seelos Therapeutics Free Cashflow Per Share ttm
Seelos Therapeutics Cash Per Share ttm
Seelos Therapeutics P/S ratio ttm
Seelos Therapeutics (GAAP) P/E ratio ttm
Seelos Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.